0000-0001-7643-6765 Employment
-
Retired Professor2025 - Present
Education
-
University of Kerala MBBS1987 - 1994
Projects & Funding
Projects & funding information is unavailable.
Publications (181)
- Dynamic Optimization of Site Management Can Accelerate Sjögren's Disease Trial Enrollment by Five Months: An In Silico Study Save
- MRT-6160, a VAV1-Directed Molecular Glue Degrader, Inhibits Disease Progression in a Preclinical Model of T/B-cell-Mediated Experimental Autoimmune Encephalomyelitis Save
- Selective Degradation of NIMA-related kinase 7 (NEK7) via a Molecular Glue Degrader Inhibits IL-1 Downstream of NLRP3 Inflammasome Activation: A Novel Therapeutic Approach for Cardiovascular Inflammation Save
- MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, INHIBITS DISEASE PROGRESSION IN A T-CELL TRANSFER MEDIATED MURINE COLITIS MODEL CONCOMITANT WITH REDUCED CALPROTECTIN EXPRESSION Save
- Effect of Ixekizumab Treatment on MRI Structural Lesions in the Sacroiliac Joints of Patients with Radiographic Axial Spondyloarthritis; A Post-hoc Analysis of a Placebo and Active Controlled RCT Save
- LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS Save
- LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS Save
- Long-term Safety of Ixekizumab in Adult Patients With Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis Save
- Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis Save
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial Save